{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:02:02Z","timestamp":1789657322507,"version":"4.0.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06191-2","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:34:22Z","timestamp":1789648462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exosomes in Alzheimer\u2019s Disease: From Pathological Mechanisms to Biomarker Potential and Therapeutic Applications"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6821-7666","authenticated-orcid":false,"given":"Arda Can","family":"Ayd\u0131n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"6191_CR1","doi-asserted-by":"crossref","unstructured":"Safiri S, et al (2024) Alzheimer\u2019s disease: a comprehensive review... Front Med. 11:1474043.","DOI":"10.3389\/fmed.2024.1474043"},{"key":"6191_CR2","unstructured":"World Health Organization. (2023) Dementia Fact Sheet. WHO."},{"key":"6191_CR3","doi-asserted-by":"crossref","unstructured":"Graff-Radford J, et al (2021) New \u0131nsights into atypical Alzheimer\u2019s disease... Lancet Neurol. 20(3):222\u2013234.","DOI":"10.1016\/S1474-4422(20)30440-3"},{"key":"6191_CR4","doi-asserted-by":"publisher","DOI":"10.4045\/tidsskr.20.0919","author":"AB Knapskog","year":"2023","unstructured":"Knapskog AB et al (2023) Alzheimers sykdom \u2013 diagnostikk og behandling. Tidsskr Nor Laegeforen. https:\/\/doi.org\/10.4045\/tidsskr.20.0919","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"2","key":"6191_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5336\/pharmsci.2019-71813","volume":"9","author":"AC Ayd\u0131n","year":"2020","unstructured":"Ayd\u0131n AC (2020) Alzheimer Hastal\u0131\u011f\u0131 ve Demans. J Lit Pharm Sci 9(2):125\u2013136","journal-title":"J Lit Pharm Sci"},{"key":"6191_CR6","doi-asserted-by":"crossref","unstructured":"Jack CR Jr et al (2018) NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14(4):535\u2013562","DOI":"10.1016\/j.jalz.2018.03.004"},{"issue":"11","key":"6191_CR7","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","volume":"14","author":"H Hampel","year":"2018","unstructured":"Hampel H et al (2018) Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nat Rev Neurol 14(11):639\u2013652","journal-title":"Nat Rev Neurol"},{"key":"6191_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH et al (2023) Lecanemab in early Alzheimer\u2019s disease. N Engl J Med 388:9\u201321","journal-title":"N Engl J Med"},{"key":"6191_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. Science. https:\/\/doi.org\/10.1126\/science.aau6977","journal-title":"Science"},{"issue":"6","key":"6191_CR10","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrneurol.2016.68","volume":"12","author":"AG Thompson","year":"2016","unstructured":"Thompson AG et al (2016) Extracellular vesicles in neurodegenerative disease: pathogenesis to biomarkers. Nat Rev Neurol 12(6):346\u2013357","journal-title":"Nat Rev Neurol"},{"key":"6191_CR11","volume":"9","author":"L Jia","year":"2021","unstructured":"Jia L et al (2021) Exosomes in Alzheimer\u2019s disease: pathogenesis, diagnosis, and therapy. Front Cell Dev Biol 9:814917","journal-title":"Front Cell Dev Biol"},{"issue":"19","key":"6191_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910794","volume":"22","author":"HM Soliman","year":"2021","unstructured":"Soliman HM et al (2021) Exosomes in Alzheimer\u2019s disease: from being pathological players to potential diagnostics and therapeutics. Int J Mol Sci 22(19):10794","journal-title":"Int J Mol Sci"},{"issue":"7","key":"6191_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3390\/cells8070727","volume":"8","author":"LM Doyle","year":"2019","unstructured":"Doyle LM, Wang MZ (2019) Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells 8(7):727","journal-title":"Cells"},{"issue":"6478","key":"6191_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. Science 367(6478):eaau6977","journal-title":"Science"},{"key":"6191_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12943-022-01671-0","volume":"21","author":"QF Han","year":"2022","unstructured":"Han QF, Li WJ, Hu KS et al (2022) Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer. Mol Cancer 21:207","journal-title":"Mol Cancer"},{"key":"6191_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","volume":"19","author":"S Gurung","year":"2021","unstructured":"Gurung S, Perocheau D, Touramanidou L, Baruteau J (2021) The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal 19:47","journal-title":"Cell Commun Signal"},{"issue":"6","key":"6191_CR17","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.4103\/1673-5374.385875","volume":"19","author":"S Gotoh","year":"2024","unstructured":"Gotoh S, Kawabori M, Fujimura M (2024) Intranasal administration of stem cell-derived exosomes for central nervous system diseases. Neural Regen Res 19(6):1249\u20131255","journal-title":"Neural Regen Res"},{"issue":"2","key":"6191_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.tcb.2023.06.006","volume":"34","author":"SB Arya","year":"2024","unstructured":"Arya SB, Collie SP, Parent CA (2024) The ins-and-outs of exosome biogenesis, secretion, and internalization. Trends Cell Biol 34(2):90\u2013108","journal-title":"Trends Cell Biol"},{"issue":"2","key":"6191_CR19","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3390\/ijms24021337","volume":"24","author":"SV Krylova","year":"2023","unstructured":"Krylova SV, Feng D (2023) The machinery of exosomes: biogenesis, release, and uptake. Int J Mol Sci 24(2):1337","journal-title":"Int J Mol Sci"},{"key":"6191_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"M Colombo","year":"2014","unstructured":"Colombo M, Raposo G, Th\u00e9ry C (2014) Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30:255\u2013289","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1","key":"6191_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","volume":"21","author":"M Mathieu","year":"2019","unstructured":"Mathieu M, Martin-Jaular L, Lavieu G, Th\u00e9ry C (2019) Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol 21(1):9\u201317","journal-title":"Nat Cell Biol"},{"issue":"19","key":"6191_CR22","doi-asserted-by":"crossref","first-page":"7272","DOI":"10.3390\/ijms21197272","volume":"21","author":"WA Banks","year":"2020","unstructured":"Banks WA, Sharma P, Bullock KM et al (2020) Transport of extracellular vesicles across the blood-brain barrier. Int J Mol Sci 21(19):7272","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6191_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/alz.12166","volume":"17","author":"L Jia","year":"2021","unstructured":"Jia L, Zhu M, Kong C et al (2021) Blood neuro-exosomal synaptic proteins predict Alzheimer\u2019s disease at the asymptomatic stage. Alzheimers Dement 17(1):49\u201360","journal-title":"Alzheimers Dement"},{"issue":"1","key":"6191_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00401-018-1868-1","volume":"136","author":"MS Sinha","year":"2018","unstructured":"Sinha MS, Ansell-Schultz A, Civitelli L et al (2018) Alzheimer\u2019s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers. Acta Neuropathol 136(1):41\u201356","journal-title":"Acta Neuropathol"},{"issue":"14","key":"6191_CR25","doi-asserted-by":"publisher","first-page":"10977","DOI":"10.1074\/jbc.M111.324616","volume":"287","author":"K Yuyama","year":"2012","unstructured":"Yuyama K, Sun H, Mitsutake S, Igarashi Y (2012) Sphingolipid-modulated exosome secretion promotes clearance of amyloid-\u03b2 by microglia. J Biol Chem 287(14):10977\u201310989","journal-title":"J Biol Chem"},{"issue":"5","key":"6191_CR26","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1074\/jbc.M114.585703","volume":"290","author":"M Grey","year":"2015","unstructured":"Grey M, Dunning CJ, Gaspar R et al (2015) Acceleration of \u03b1-synuclein aggregation by exosomes. J Biol Chem 290(5):2969\u20132982","journal-title":"J Biol Chem"},{"key":"6191_CR27","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/s41374-021-00644-z","volume":"101","author":"E Miyoshi","year":"2021","unstructured":"Miyoshi E, Bilousova T, Melnik M et al (2021) Exosomal tau with seeding activity is released from Alzheimer\u2019s disease synapses, and seeding potential is associated with amyloid beta. Lab Invest 101:1605\u20131617","journal-title":"Lab Invest"},{"key":"6191_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00698","volume":"13","author":"M P\u00e9rez","year":"2019","unstructured":"P\u00e9rez M, Avila J, Hern\u00e1ndez F (2019) Propagation of tau via extracellular vesicles. Front Neurosci 13:698","journal-title":"Front Neurosci"},{"issue":"8","key":"6191_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081800","volume":"10","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Liu B, Wang J et al (2022) A\u03b2 and tau regulate microglia metabolism via exosomes in Alzheimer\u2019s disease. Biomedicines 10(8):1800","journal-title":"Biomedicines"},{"key":"6191_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.974414","volume":"14","author":"NA Jackson","year":"2022","unstructured":"Jackson NA, Guerrero-Mu\u00f1oz MJ, Castillo-Carranza DL (2022) The prion-like transmission of tau oligomers via exosomes. Front Aging Neurosci 14:974414","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"6191_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cells8091059","volume":"8","author":"CA Elia","year":"2019","unstructured":"Elia CA, Tamborini M, Rasile M et al (2019) Intracerebral injection of extracellular vesicles from mesenchymal stem cells exerts reduced A\u03b2 plaque burden in early stages of a preclinical model of Alzheimer\u2019s disease. Cells 8(9):1059","journal-title":"Cells"},{"key":"6191_CR32","doi-asserted-by":"publisher","first-page":"6891","DOI":"10.1111\/febs.16055","volume":"289","author":"JC Polanco","year":"2022","unstructured":"Polanco JC, G\u00f6tz J (2022) Exosomal and vesicle-free tau seeds\u2014propagation and convergence in endolysosomal permeabilization. FEBS J 289:6891\u20136907","journal-title":"FEBS J"},{"key":"6191_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fnins.2017.00229","volume":"11","author":"K Yuyama","year":"2017","unstructured":"Yuyama K, Igarashi Y (2017) Exosomes as carriers of Alzheimer\u2019s amyloid-\u00df. Front Neurosci 11:229","journal-title":"Front Neurosci"},{"issue":"1","key":"6191_CR34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/brain\/awaa376","volume":"144","author":"Z Ruan","year":"2021","unstructured":"Ruan Z et al (2021) Alzheimer\u2019s disease brain-derived extracellular vesicles propagate tau pathology in wild-type mice. Brain 144(1):288\u2013309","journal-title":"Brain"},{"key":"6191_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00698","volume":"13","author":"M P\u00e9rez","year":"2019","unstructured":"P\u00e9rez M, Avila J, Hern\u00e1ndez F (2019) Propagation of tau via extracellular vesicles. Front Neurosci 13:698","journal-title":"Front Neurosci"},{"key":"6191_CR36","doi-asserted-by":"publisher","first-page":"6891","DOI":"10.1111\/febs.16055","volume":"289","author":"JC Polanco","year":"2022","unstructured":"Polanco JC, G\u00f6tz J (2022) Exosomal and vesicle-free tau seeds\u2014propagation and convergence in endolysosomal permeabilization. FEBS J 289:6891\u20136907","journal-title":"FEBS J"},{"issue":"11","key":"6191_CR37","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai H, Ikezu S, Tsunoda S et al (2015) Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci 18(11):1584\u20131593","journal-title":"Nat Neurosci"},{"key":"6191_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.586731","volume":"13","author":"S Jiang","year":"2020","unstructured":"Jiang S, Bhaskar K (2020) Degradation and transmission of tau by autophagic-endolysosomal networks and potential therapeutic targets for tauopathy. Front Mol Neurosci 13:586731","journal-title":"Front Mol Neurosci"},{"key":"6191_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.974414","volume":"14","author":"NA Jackson","year":"2022","unstructured":"Jackson NA, Guerrero-Mu\u00f1oz MJ, Castillo-Carranza DL (2022) The prion-like transmission of tau oligomers via exosomes. Front Aging Neurosci 14:974414","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"6191_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000837","volume":"18","author":"J Xu","year":"2020","unstructured":"Xu J et al (2020) Peli1 impairs microglial A\u03b2 phagocytosis through promoting C\/EBP\u03b2 degradation in Alzheimer\u2019s disease. PLoS Biol 18(8):e3000837","journal-title":"PLoS Biol"},{"key":"6191_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01761-0","volume":"17","author":"X Long","year":"2020","unstructured":"Long X, Yao X, Jiang Q et al (2020) Astrocyte-derived exosomes enriched with miR-873a-5p inhibit neuroinflammation via microglia phenotype modulation after traumatic brain injury. J Neuroinflammation 17:89","journal-title":"J Neuroinflammation"},{"issue":"5","key":"6191_CR42","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/brain\/awaa090","volume":"143","author":"M Guo","year":"2020","unstructured":"Guo M, Wang J, Zhao Y et al (2020) Microglial exosomes facilitate \u03b1-synuclein transmission in Parkinson\u2019s disease. Brain 143(5):1476\u20131497","journal-title":"Brain"},{"key":"6191_CR43","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12951-022-01332-w","volume":"20","author":"X Xian","year":"2022","unstructured":"Xian X, Cai LL, Li Y et al (2022) Neuron secrete exosomes containing miR-9-5p to promote polarization of M1 microglia in depression. J Nanobiotechnology 20:202","journal-title":"J Nanobiotechnology"},{"key":"6191_CR44","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12951-022-01522-6","volume":"20","author":"T Hua","year":"2022","unstructured":"Hua T, Yang M, Song H et al (2022) Huc-MSCs-derived exosomes attenuate inflammatory pain by regulating microglia pyroptosis and autophagy via the miR-146a-5p\/TRAF6 axis. J Nanobiotechnology 20:324","journal-title":"J Nanobiotechnology"},{"key":"6191_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01724-y","author":"W Xiong","year":"2022","unstructured":"Xiong W, Li C, Kong G et al (2022) Treg cell-derived exosomes miR-709 attenuates microglia pyroptosis and promotes motor function recovery after spinal cord injury. J Nanobiotechnology. https:\/\/doi.org\/10.1186\/s12951-022-01724-y","journal-title":"J Nanobiotechnology"},{"issue":"12","key":"6191_CR46","volume":"29","author":"J Che","year":"2023","unstructured":"Che J, Wang H, Dong J et al (2023) Human umbilical cord mesenchymal stem cell-derived exosomes attenuate neuroinflammation and oxidative stress through the NRF2\/NF-\u03baB\/NLRP3 pathway. CNS Neurosci Ther 29(12):e14454","journal-title":"CNS Neurosci Ther"},{"key":"6191_CR47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12974-022-02594-9","volume":"19","author":"O Akinduro","year":"2022","unstructured":"Akinduro O, Kumar S, Chen Y et al (2022) Human breast milk-derived exosomes attenuate lipopolysaccharide-induced activation in microglia. J Neuroinflammation 19:241","journal-title":"J Neuroinflammation"},{"key":"6191_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113895","volume":"347","author":"J Zhang","year":"2022","unstructured":"Zhang J, Buller BA, Zhang ZG et al (2022) Exosomes derived from bone marrow mesenchymal stromal cells promote remyelination and reduce neuroinflammation in the demyelinating central nervous system. Exp Neurol 347:113895","journal-title":"Exp Neurol"},{"key":"6191_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00038","volume":"13","author":"S Hornung","year":"2020","unstructured":"Hornung S, Dutta S, Bitan G (2020) CNS-derived blood exosomes as a promising source of biomarkers: opportunities and challenges. Front Mol Neurosci 13:38. https:\/\/doi.org\/10.3389\/fnmol.2020.00038","journal-title":"Front Mol Neurosci"},{"key":"6191_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00053","volume":"13","author":"L Wang","year":"2020","unstructured":"Wang L, Zhang L (2020) Circulating exosomal miRNA as diagnostic biomarkers of neurodegenerative diseases. Front Mol Neurosci 13:53. https:\/\/doi.org\/10.3389\/fnmol.2020.00053","journal-title":"Front Mol Neurosci"},{"key":"6191_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.580199","volume":"12","author":"X Dong","year":"2020","unstructured":"Dong X, Zheng D, Nao J (2020) Circulating exosome microRNAs as diagnostic biomarkers of dementia. Front Aging Neurosci 12:580199. https:\/\/doi.org\/10.3389\/fnagi.2020.580199","journal-title":"Front Aging Neurosci"},{"key":"6191_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/cells10050993","volume":"10","author":"F Delgado-Peraza","year":"2021","unstructured":"Delgado-Peraza F, Nogueras-Ortiz CJ, Volpert O et al (2021) Neuronal and astrocytic extracellular vesicle biomarkers in blood reflect brain pathology in mouse models of Alzheimer\u2019s disease. Cells 10:993. https:\/\/doi.org\/10.3390\/cells10050993","journal-title":"Cells"},{"key":"6191_CR53","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/cns.13846","volume":"28","author":"Y Li","year":"2022","unstructured":"Li Y, Meng S, Di W et al (2022) Amyloid-\u03b2 protein and MicroRNA-384 in NCAM-labeled exosomes from peripheral blood are potential diagnostic markers for Alzheimer\u2019s disease. CNS Neurosci Ther 28:1093\u20131107. https:\/\/doi.org\/10.1111\/cns.13846","journal-title":"CNS Neurosci Ther"},{"key":"6191_CR54","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3892\/mmr.2020.11118","volume":"22","author":"D Wang","year":"2020","unstructured":"Wang D, Wang P, Bian X et al (2020) Elevated plasma levels of exosomal BACE1-AS combined with the volume and thickness of the right entorhinal cortex may serve as a biomarker for the detection of Alzheimer\u2019s disease. Mol Med Rep 22:227\u2013238. https:\/\/doi.org\/10.3892\/mmr.2020.11118","journal-title":"Mol Med Rep"},{"key":"6191_CR55","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13195-020-00670-x","volume":"12","author":"M Guo","year":"2020","unstructured":"Guo M et al (2020) Mesenchymal stem cell-derived exosome: a promising alternative in the therapy of Alzheimer\u2019s disease. Alzheimers Res Ther 12:109","journal-title":"Alzheimers Res Ther"},{"key":"6191_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-025-04318-1","author":"H Li","year":"2025","unstructured":"Li H, Bai L (2025) Advances in mesenchymal stem cell and exosome-based therapies for aging and age-related diseases. Stem Cell Res Ther. https:\/\/doi.org\/10.1186\/s13287-025-04318-1","journal-title":"Stem Cell Res Ther"},{"key":"6191_CR57","doi-asserted-by":"crossref","unstructured":"Chen YA, et al (2021) Mesenchymal stem cell-derived exosomes ameliorate Alzheimer\u2019s disease pathology... Biomedicines. 9:594.","DOI":"10.3390\/biomedicines9060594"},{"issue":"9","key":"6191_CR58","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/sctm.19-0327","volume":"9","author":"M Losurdo","year":"2020","unstructured":"Losurdo M, Pedrazzoli M, D\u2019Agostino C et al (2020) Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer\u2019s disease. Stem Cells Transl Med 9(9):1068\u20131084","journal-title":"Stem Cells Transl Med"},{"key":"6191_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26083915","volume":"26","author":"YP Yang","year":"2025","unstructured":"Yang YP, Nicol CJB, Chiang MC (2025) A review of the neuroprotective properties of exosomes derived from stem cells and exosome-coated nanoparticles for treating neurodegenerative diseases and stroke. Int J Mol Sci 26:3915","journal-title":"Int J Mol Sci"},{"key":"6191_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17081041","volume":"17","author":"HM Yang","year":"2025","unstructured":"Yang HM (2025) Overcoming the blood-brain barrier: advanced strategies in targeted drug delivery for neurodegenerative diseases. Pharmaceutics 17:1041","journal-title":"Pharmaceutics"},{"key":"6191_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-024-01520-7","volume":"40","author":"G Chunhui","year":"2025","unstructured":"Chunhui G, Yanqiu Y, Jibing C et al (2025) Exosomes and non-coding RNAs: bridging the gap in Alzheimer\u2019s pathogenesis and therapeutics. Metab Brain Dis 40:84","journal-title":"Metab Brain Dis"},{"issue":"9","key":"6191_CR62","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3390\/cells8091059","volume":"8","author":"CA Elia","year":"2019","unstructured":"Elia CA, Tamborini M, Rasile M et al (2019) Intracerebral injection of extracellular vesicles from mesenchymal stem cells reduces A\u03b2 plaque burden in early-stage Alzheimer\u2019s disease models. Cells 8(9):1059","journal-title":"Cells"},{"issue":"16","key":"6191_CR63","first-page":"4981","volume":"9","author":"GH Cui","year":"2019","unstructured":"Cui GH, Guo HD, Li H et al (2019) RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in Alzheimer\u2019s disease mice. Theranostics 9(16):4981\u20134994","journal-title":"Theranostics"},{"issue":"1","key":"6191_CR64","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41418-020-0592-2","volume":"28","author":"G Santamaria","year":"2021","unstructured":"Santamaria G et al (2021) Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer\u2019s mice. Cell Death Differ 28(1):203\u2013218. https:\/\/doi.org\/10.1038\/s41418-020-0592-2","journal-title":"Cell Death Differ"},{"key":"6191_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-018-0240-6","volume":"9","author":"N Perets","year":"2018","unstructured":"Perets N, Hertz S, London M, Offen D (2018) Intranasal administration of exosomes derived from mesenchymal stem cells ameliorates autistic-like behaviors of BTBR mice. Mol Autism 9:57","journal-title":"Mol Autism"},{"key":"6191_CR66","doi-asserted-by":"publisher","first-page":"1562565","DOI":"10.3389\/fcell.2025.1562565","volume":"13","author":"D Yang","year":"2025","unstructured":"Yang D, Deng Z, Zhou H et al (2025) Exosome-mediated dual drug delivery of curcumin and methylene blue for enhanced cognitive function and mechanistic elucidation in Alzheimer\u2019s disease therapy. Front Cell Dev Biol 13:1562565","journal-title":"Front Cell Dev Biol"},{"key":"6191_CR67","unstructured":"ClinicalTrials.gov. (2025) Exosome-based therapeutic approaches for neurodegenerative diseases and Alzheimer\u2019s disease.\u00a0"},{"key":"6191_CR68","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2023-101143","volume":"36","author":"X Xie","year":"2023","unstructured":"Xie X, Song Q, Dai C et al (2023) Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer\u2019s disease: a phase I\/II clinical trial. Gen Psychiatr 36:e101143","journal-title":"Gen Psychiatr"},{"issue":"6","key":"6191_CR69","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.4103\/1673-5374.385875","volume":"19","author":"S Gotoh","year":"2024","unstructured":"Gotoh S, Kawabori M, Fujimura M (2024) Intranasal administration of stem cell-derived exosomes for central nervous system diseases. Neural Regen Res 19(6):1249\u20131255","journal-title":"Neural Regen Res"},{"key":"6191_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70548","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Li Z, Guan H, Qiu Z, Zou C (2025) Engineering exosomes for Alzheimer\u2019s disease: multi-target therapeutic strategies from pathogenesis to clinical translation. Clin Transl Med 15:e70548","journal-title":"Clin Transl Med"},{"issue":"2","key":"6191_CR71","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3233\/JAD-180578","volume":"69","author":"M Mustapic","year":"2019","unstructured":"Mustapic M, Tran J, Craft S, Kapogiannis D (2019) Extracellular vesicle biomarkers track cognitive changes following intranasal insulin in Alzheimer\u2019s disease. J Alzheimers Dis 69(2):489\u2013498","journal-title":"J Alzheimers Dis"},{"key":"6191_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03352-8","volume":"23","author":"S Mehdizadeh","year":"2025","unstructured":"Mehdizadeh S, Mamaghani M, Hassanikia S et al (2025) Exosome-powered neuropharmaceutics: unlocking the blood-brain barrier for next-gen therapies. J Nanobiotechnol 23:329","journal-title":"J Nanobiotechnol"},{"key":"6191_CR73","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1002\/alz.13823","volume":"20","author":"A Badhwar","year":"2024","unstructured":"Badhwar A, Hirschberg Y, Valle-Tamayo N et al (2024) Assessment of brain-derived extracellular vesicle enrichment for blood biomarker analysis in age-related neurodegenerative diseases: An international overview. Alzheimer\u2019s & Dementia 20:4411\u20134422","journal-title":"Alzheimer's & Dementia"},{"key":"6191_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1539714","volume":"12","author":"N Odehnalov\u00e1","year":"2025","unstructured":"Odehnalov\u00e1 N, \u0160andrikov\u00e1 V, Hromadka R et al (2025) The potential of exosomes in regenerative medicine and in the diagnosis and therapies of neurodegenerative diseases and cancer. Front Med 12:1539714","journal-title":"Front Med"},{"key":"6191_CR75","first-page":"153","volume":"37","author":"AM Larey","year":"2024","unstructured":"Larey AM, Spoerer TM, Daga KR et al (2024) High throughput screening of mesenchymal stromal cell morphological response to inflammatory signals for bioreactor-based manufacturing of extracellular vesicles that modulate microglia. Bioact Mater 37:153\u2013171","journal-title":"Bioact Mater"},{"issue":"2","key":"6191_CR76","doi-asserted-by":"publisher","first-page":"478","DOI":"10.4103\/NRR.NRR-D-24-00720","volume":"21","author":"H Chen","year":"2026","unstructured":"Chen H, Li N, Cai Y et al (2026) Exosomes in neurodegenerative diseases: therapeutic potential and modification methods. Neural Regen Res 21(2):478\u2013490","journal-title":"Neural Regen Res"},{"issue":"8","key":"6191_CR77","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v17.i8.109006","volume":"17","author":"XQ Shan","year":"2025","unstructured":"Shan XQ, He MH, Gao WL et al (2025) Mesenchymal stem cell-derived exosomes: shaping the next era of Alzheimer\u2019s disease treatment. World J Stem Cells 17(8):109006","journal-title":"World J Stem Cells"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06191-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06191-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06191-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:02:51Z","timestamp":1789653771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06191-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6191"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06191-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"9 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"904"}}